Last reviewed · How we verify
NCT05631873: ColoSET
Colonoscopy Screening: Setting Epic Follow-up Times
NA trial testing Assistance with implementing Epic Smartlist in Concordance Between Colonoscopy Follow up Interval Noted in Patient Letters vs. Electronic Health Record Chart in 43 participants. Completed in 11 March 2024.
30 September 2023
Quick facts
| Lead sponsor | Massachusetts General Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 43 |
| Start date | 18 November 2022 |
| Primary completion | 30 September 2023 |
| Estimated completion | 11 March 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Assistance with implementing Epic Smartlist
Conditions studied
- Concordance Between Colonoscopy Follow up Interval Noted in Patient Letters vs. Electronic Health Record Chart — all drugs for Concordance Between Colonoscopy Follow up Interval Noted in Patient Letters vs. Electronic Health Record Chart →
- Colorectal Cancer — all drugs for Colorectal Cancer →
Sponsor
Massachusetts General Hospital
Who can join
Eligibility, any sex, with Concordance Between Colonoscopy Follow up Interval Noted in Patient Letters vs. Electronic Health Record Chart or Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Screening for colorectal cancer can reduce its incidence and mortality but is a complex, error-prone process. The value of screening with colonoscopy is in removing pre-cancerous polyps that increase one's risk for future cancer. Abnormal results are common, and failure to receive recommended follow-up undermines the benefits of screening, violates the trust that patients place in their providers, and increases medicolegal risk. This proposal seeks to ensure that the foundation of safety systems, the recommendations for the follow-up interval reflect current guideline recommendations and are accurately updated. Specifically, the investigators will implement and evaluate in a randomized trial a new colonoscopy result letter as part of usual care that automatically updates the recommended follow-up interval in the patient's health record compared to the current result letter format.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Current Progress in Clinical Research in Secondary Prevention and Early Detection of Colorectal Cancer.
Partyka O, Pajewska M, Czerw A, Deptała A, et al · · 2025 · cited 2× · PMID 39941735 · DOI 10.3390/cancers17030367
Verify or expand the search:
- PubMed search for NCT05631873
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Massachusetts General Hospital trials
Trials by the same sponsor.
- NCT03585946 — Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis · withdrawn
- NCT07214831 — A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerg · NA · not yet recruiting
- NCT06686901 — A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior · NA · not yet recruiting
- NCT05854212 — Behavioral Economics to Implement Nutrition Ranking in Food Pantries · NA · not yet recruiting
- NCT07323446 — The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05631873 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Massachusetts General Hospital
- Last refreshed: 12 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05631873.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing